Skip to main content

MoneyWorks4Me

Cadila Healthcare informs about press release

17 Apr 2019 Evaluate

Cadila Healthcare has informed about submission of a press release titled ‘Zydus Announces Phase 3 Trial of Desidustat in Non-Dialysis Dependent Chronic Kidney Disease (CKD) Patients with Anemia’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..